Testing effectiveness (Phase 2)Study completedNCT02682693
What this trial is testing
Denosumab as an add-on Neoadjuvant Treatment (GeparX)
Who this might be right for
Breast Cancer Female NOSTubular Breast Cancer Stage IIMucinous Breast Cancer Stage II+4 more
GBG Forschungs GmbH 780